Dr. Parikh received his medical degree from Seth G.S. Medical College and KEM Hospital in Mumbai, India and subsequently completed his Nephrology fellowship and a PhD in Clinical Investigation at the University of Colorado Health Sciences Center. Dr. Parikh’s research focuses on the translation and validation of novel biomarkers for the diagnosis and prognosis of acute kidney injury. Progress in kidney diseases has been hamstrung by significant heterogeneity within the current disease definitions, which are largely based on serum creatinine. Dr. Parikh’s research has addressed this critical challenge by developing biomarkers of renal tubular injury, repair, and inflammation to dissect this heterogeneity. He has assembled multicenter longitudinal prospective cohorts for translational research studies across several clinical settings of acute kidney injury and chronic kidney disease for the efficient translation of novel biomarkers. His research is dedicated to the process of applying discoveries generated in the laboratory and in preclinical experiments, the development of clinical studies, and the design of clinical trials. Dr. Parikh’s studies have refined the clinical definition in perioperative acute kidney injury and hepatorenal syndrome, developed strategies to reduce kidney discard in deceased donor transplantation, and advanced regulatory approvals of kidney injury biomarkers. He has also developed biomarkers to identify rapid progressors of early diabetic kidney disease before derangements in serum creatinine. Dr. Parikh’s research goal is to translate our understanding of pathophysiological mechanisms into clinical practice and improve the outcomes in patients with kidney disease. Dr. Parikh has also been the recipient of numerous honors, including the 2017 Young Investigator Award from the American Society of Nephrology. Dr. Parikh is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Interstitial Nephritis, Acute Tubular Necrosis, Prerenal Azotemia, Kidney Transplant, and Nephrectomy.

Akshay Amin is a Nephrologist in Lutherville, Maryland. Dr. Amin is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and Diabetic Nephropathy. Dr. Amin is currently accepting new patients.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Matthew Weir is a Nephrologist in Baltimore, Maryland. Dr. Weir is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are High Potassium Level, Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Kidney Transplant, and Nephrectomy. Dr. Weir is currently accepting new patients.

Jin Gu is a primary care provider, practicing in Internal Medicine in Towson, Maryland. Dr. Gu is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, Bone Marrow Aspiration, and Endoscopy.

Ibikunle Koya is a Nephrologist in Lutherville, Maryland. Dr. Koya is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, End-Stage Renal Disease (ESRD), and Acute Kidney Failure. Dr. Koya is currently accepting new patients.

Tedine Ranich is a Nephrologist in Lutherville, Maryland. Dr. Ranich is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Kidney Failure, and End-Stage Renal Disease (ESRD). Dr. Ranich is currently accepting new patients.

Mark Corriere is an Endocrinologist in Towson, Maryland. Dr. Corriere is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Thyroid Nodule, and Hypothyroidism.

Dr. Derek M. Fine is an associate professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include glomerular kidney disease, particularly lupus nephritis and other immune-mediated kidney diseases, HIV-related kidney disease, scleroderma-related kidney disease, acute kidney injury, hyponatremia, kidney biopsy, and rhabdomyolysis. Dr. Fine earned his M.D. at Johns Hopkins. He completed his residency in internal medicine and his fellowship in nephrology at Johns Hopkins. His research interests include HIV-related kidney diseases and lupus nephritis. He is a member of the Miller Coulson Academy of Clinical Excellence and was named 2018 Physician of the Year at Johns Hopkins Hospital. Dr. Fine is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Lupus Nephritis, Glomerulonephritis, Systemic Lupus Erythematosus (SLE), Chronic Kidney Disease, and Kidney Transplant.

Dr. Scott Pilla earned his M.D. at Robert Wood Johnson Medical School and completed his residency at Johns Hopkins Bayview Medical Center. He completed the Johns Hopkins General Internal Medicine Fellowship in clinical research in 2018. Dr. Pilla is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Obesity.

Dr. Rameen J. Molavi is part-time on the medical faculty as an instructor in medicine in the division of General Internal Medicine within the Department of Medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is internal medicine. Dr. Molavi is also the managing physician and chair of Park Medical Associates, a member of Johns Hopkins Regional Physicians. He is the recipient of the 2025 Samuel P. Asper Award for excellence in medicine from the Maryland Chapter of the American College of Physicians. Dr. Molavi holds a B.A. in biology from Rice University in Houston, TX. He earned his M.D. at the Johns Hopkins University School of Medicine. He completed his internship and residency in categorical internal medicine at the Washington University School of Medicine Barnes-Jewish Hospital in St. Louis, MO. He began medical practice in Lutherville in 1999 and joined Park Medical Associates in 2009. His practice focus is on primary care for adults of all ages. Recent News Articles and Media Coverage Dr. Rameen Molavi: COVID-19 Testing Realities, WYPR (April 28, 2020) Samuel Asper Award, American College of Physicians (2025). Dr. Molavi is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Mesenteric Venous Thrombosis, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Hypertension.

Anita Pasumarthy is a Nephrologist in Baltimore, Maryland. Dr. Pasumarthy is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, End-Stage Renal Disease (ESRD), and Chronic Kidney Disease.

Mohamed G. Atta, MD, MPH, is Professor of Medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland and Director of Von Hippel Lindau Clinical Care Center at Hopkins. A graduate of Mansoura University School of Medicine in Egypt, he completed his internship and residency training in various locations including the Urology and Nephrology Center at Mansoura University, Cabrini Medical Center in New York, and Johns Hopkins University School of Medicine. Dr. Atta received his MPH degree from Johns Hopkins Bloomberg School of Public Health in 2005. Dr. Atta is a member of the Health Disparity Committee at the Department of Health and Mental Hygiene in Maryland, the Scientific Council on Kidney of the American Heart Association, the International Society of Nephrology, and the American Society of Nephrology. Dr. Atta has participated as principal investigator in several studies, clinical trials, and serves as a peer reviewer for the Journal of Clinical Investigation, Archives of Internal Medicine, American Journal of Medicine, Kidney International, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Clinical Infectious Disease, and Journal of Infectious Diseases among others. He authored or co-authored numerous articles published in Genomics, the Journal of Biological Chemistry, Journal of clinical investigation, Clinical Infectious Disease, Circulation, Stem Cells Translational Medicine, American Journal of Medicine, and American Journal of Transplantation, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Disease, Nephrology Dialysis Transplantation, and Kidney International, among others. Dr. Atta is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are End-Stage Renal Disease (ESRD), Glomerulonephritis, Lupus Nephritis, Chronic Kidney Disease, and Kidney Transplant.

Jeffrey Posner is a Nephrologist in Owings Mills, Maryland. Dr. Posner is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, End-Stage Renal Disease (ESRD), and Chronic Kidney Disease. Dr. Posner is currently accepting new patients.

Justin Tcheugui is an Endocrinologist in Baltimore, Maryland. Dr. Tcheugui is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Gestational Diabetes.

Albert Deloskey is a primary care provider, practicing in Internal Medicine in Towson, Maryland. Dr. Deloskey is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are High Cholesterol, Familial Combined Hyperlipidemia, Xanthoma, and Cirrhosis. Dr. Deloskey is currently accepting new patients.

Mari Blackburn is a primary care provider, practicing in Family Medicine in Towson, Maryland. Dr. Blackburn is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Dilated Cardiomyopathy (DCM), Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Diabetic Nephropathy.

Vincent Dipietro is a primary care provider, practicing in Internal Medicine in Towson, Maryland. Dr. Dipietro is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Type 2 Diabetes (T2D), Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Hypertension. Dr. Dipietro is currently accepting new patients.

Marc Sokolow is a primary care provider, practicing in Geriatrics and Internal Medicine in Towson, Maryland. Dr. Sokolow is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Sitosterolemia, Fish Tapeworm Infection, Acute Cystitis, and High Cholesterol. Dr. Sokolow is currently accepting new patients.

Lonnie Fuller is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Fuller is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Cardiomyopathy Due to Anthracyclines, Doxorubicin-Induced Cardiomyopathy, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Fuller is currently accepting new patients.